Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
Clinical trial NCT00184015 · UNKNOWN
Trial details
- NCT number
- NCT00184015
- Sponsor
- University of Southern California
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-18
- Primary completion
- 2016-08-21
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.